https://www.selleckchem.com/products/lxs-196.html
In the reference scenario, the total cost for treatment of the 3453 VL confirmed cases in 2014 was $1 447 611.75. The incremental budget impact with the use of liposomal amphotericin B for all the VL confirmed cases was $299 646.43 in the third year. The analysis presented will support the decision process for the use and expansion of liposomal amphotericin B for all VL confirmed cases in Brazil. The analysis presented will support the decision process for the use and expansion of liposomal amphotericin B for all VL confirmed cases in B